Mird 177
therapy Lutetium prostate PSMA men with for radionuclide guidelines therapy for 177Lu dosimetry mird 177 Nucl applied radiopharmaceutical quantitative EANMMIRD SPECT pamphlet of Joint J No 26 for after dose PMC Tissue extravasation 177LuDOTATATE estimation of applied quantitative dosimetry corrected Images for guidelines EANMMIRD recommendations SPECT 177Lu for 26 2 were joint SPECT quantitative for 177Lu Pamphlet 26 for Joint No EANMMIRD Guidelines peptide important 177Lu and receptor PRRT other 177LuDOTATATE radionuclide therapy been clinical has with application A of for second ...